In order to assess the changes in mitochondrial biogenesis and content, clinical studies have revealed a significant reduction in the expression levels of PGC-1α and TFAM in peripheral mononuclear cells of patients with ALS (Araujo, 2020). Here, PPARGC1A is linked to amyotrophic lateral sclerosis.